Effect of 8 weeks oral pentaerithrityltetranitrate on endothelial dysfunction in patients with coronary artery disease: a prospective, randomized, double-blind, placebo-controlled, monocentric clinical trial of phase IV

2013 ◽  
Author(s):  
Ascan Warnholtz
Sign in / Sign up

Export Citation Format

Share Document